Oxygenta Pharmaceutical Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹9.18Cr |
Net Profits | ₹-3.78Cr |
Net Profit Margins | -41.18% |
Highlights
Revenue:
Oxygenta Pharmaceutical Ltd’s revenue jumped 16.65% since last year same period to ₹9.18Cr in the Q3 2023-2024. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated -29.82% fall in its revenue since last 3-months.
Net Profits:
Oxygenta Pharmaceutical Ltd’s net profit fell -16.31% since last year same period to ₹-3.78Cr in the Q3 2023-2024. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated -19.62% fall in its net profits since last 3-months.
Net Profit Margins:
Oxygenta Pharmaceutical Ltd’s net profit margin jumped 0.29% since last year same period to -41.18% in the Q3 2023-2024. On a quarterly growth basis, Oxygenta Pharmaceutical Ltd has generated -70.44% fall in its net profit margins since last 3-months.
